Abstract:Epidermal growth factor receptors (EGFR) are primarily engaged in the regulation of fundamental cellular processes. Overexpression and mutations in these tyrosine kinases cause a variety of malignancies, including lung cancer. The current study addresses the suppression of inactive and mutant variants of the EGFR target site via two primary proposals: (1) To prevent the formation of its mutant form by inhibiting inactive EGFR. (2) To suppress the mutant EGFR directly. After the virtual screening of a newly designed series of hybrid models, selected molecules were synthesized and well-characterized from various spectroscopic and spectrometric methods. The critical analysis and chemistry behind the structural interactions of the selected compounds with three target sites were discussed i.e., inactive EGFR (PDB code: 1XKK), mutant EGFR (PDB code: 3W2O), and allosteric site of mutant EGFR (PDB code: 6P1L). It was observed that compound 7 showed effective results in terms of docking score, structural interactions as well as orientation in the binding pocket towards the inactive target site. Whereas, compound 8 exhibited all the above-mentioned features excellently against mutant EGFR. Apart from that, the investigations were expanded to study the structural behaviour in the allosteric site, where compound 8 once again performed effectively. Such proposals were further clarified by running molecular dynamics (MD) simulation for 100 ns towards inactive, mutant, and allosteric sites of mutant EGFR. Where compounds 7, and 8 demonstrated highly consistence behaviour during the whole simulation trajectory. Further, in vitro results of EGFR inhibition assay and anti-proliferative activity were found in accordance with the computational findings. For the EGFR inhibition assay, compounds 7, and 8 showed excellent IC50 values of 20.7, and 22.5 μM respectively. Moreover, IC50 values exhibited by both the compounds in anti-proliferative activity were observed to be 27.5, and 11.7 μM respectively. Thus, compounds 7 and 8 may have potential to become good anticancer agents.

Discovery of Hyperstable Noncanonical Plant-Derived Epidermal Growth Factor Receptor Agonist and Analogs

Hyperstable EGF-like bleogen derived from cactus accelerates corneal healing in rats

Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders

Progress in Human Epidermal Growth Factor Research

Plasiatine, an Unprecedented Indole–Phenylpropanoid Hybrid from Plantago Asiatica As a Potent Activator of the Nonreceptor Protein Tyrosine Phosphatase Shp2

Discovery of a Series of Novel Phenylpiperazine Derivatives As EGFR TK Inhibitors

Potential of Epidermal Growth Factor-like Peptide from the Sea Cucumber Stichopus horrens to Increase the Growth of Human Cells: In Silico Molecular Docking Approach

[Epidermal growth factor, innovation and safety]

Discovery of Novel Epidermal Growth Factor Receptor (EGFR) Inhibitors Using Computational Approaches

Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth

Identification and Characterization of a Novel Peptide Ligand of Epidermal Growth Factor Receptor for Targeted Delivery of Therapeutics.

Discovery of a Highly Potent and Broadly Effective Epidermal Growth Factor Receptor and HER2 Exon 20 Insertion Mutant Inhibitor

Analysis of Skin Regeneration and Barrier-Improvement Efficacy of Polydeoxyribonucleotide Isolated from Panax Ginseng (C.A. Mey.) Adventitious Root

Molecular Pharming of the Recombinant Protein hEGF-hEGF Concatenated with Oleosin Using Transgenic Arabidopsis

Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-b]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors

Discovery of a novel short peptide with efficacy in accelerating the healing of skin wounds

Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors

Discovery of Cyclic Peptidomimetic Ligands Targeting the Extracellular Domain of EGFR

Comprehensive analysis and outcomes of hybridization of physiologically active heterocycles targeting epidermal growth factor receptor (EGFR)

Identification of New Peptide Ligands for Epidermal Growth Factor Receptor Using Phage Display and Computationally Modeling their Mode of Binding

Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors